Your browser doesn't support javascript.
loading
Structural surfaceomics reveals an AML-specific conformation of integrin ß2 as a CAR T cellular therapy target.
Mandal, Kamal; Wicaksono, Gianina; Yu, Clinton; Adams, Jarrett J; Hoopmann, Michael R; Temple, William C; Izgutdina, Adila; Escobar, Bonell Patiño; Gorelik, Maryna; Ihling, Christian H; Nix, Matthew A; Naik, Akul; Xie, William H; Hübner, Juwita; Rollins, Lisa A; Reid, Sandy M; Ramos, Emilio; Kasap, Corynn; Steri, Veronica; Serrano, Juan Antonio Camara; Salangsang, Fernando; Phojanakong, Paul; McMillan, Melanie; Gavallos, Victor; Leavitt, Andrew D; Logan, Aaron C; Rooney, Cliona M; Eyquem, Justin; Sinz, Andrea; Huang, Benjamin J; Stieglitz, Elliot; Smith, Catherine C; Moritz, Robert L; Sidhu, Sachdev S; Huang, Lan; Wiita, Arun P.
Afiliación
  • Mandal K; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Wicaksono G; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Yu C; Department of Physiology and Biophysics, University of California Irvine, Irvine, CA, USA.
  • Adams JJ; The Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.
  • Hoopmann MR; School of Pharmacy, University of Waterloo, Kitchener, Ontario, Canada.
  • Temple WC; Institute for Systems Biology, Seattle, WA, USA.
  • Izgutdina A; Department of Pediatrics, Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA, USA.
  • Escobar BP; Department of Pediatrics, Division of Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, San Francisco, CA, USA.
  • Gorelik M; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Ihling CH; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Nix MA; The Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.
  • Naik A; Department of Pharmaceutical Chemistry and Bioanalytics, Institute of Pharmacy, Martin-Luther University Halle-Wittenberg, Halle, Germany.
  • Xie WH; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Hübner J; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Rollins LA; UCSF/Gladstone Institute for Genomic Immunology, San Francisco, CA, USA.
  • Reid SM; Department of Pediatrics, Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA, USA.
  • Ramos E; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.
  • Kasap C; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital-Texas Children's Hospital, Houston, TX, USA.
  • Steri V; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital-Texas Children's Hospital, Houston, TX, USA.
  • Serrano JAC; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Salangsang F; Department of Medicine, Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA, USA.
  • Phojanakong P; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.
  • McMillan M; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.
  • Gavallos V; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.
  • Leavitt AD; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.
  • Logan AC; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Rooney CM; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Eyquem J; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Sinz A; Department of Medicine, Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA, USA.
  • Huang BJ; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital-Texas Children's Hospital, Houston, TX, USA.
  • Stieglitz E; UCSF/Gladstone Institute for Genomic Immunology, San Francisco, CA, USA.
  • Smith CC; Department of Medicine, Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA, USA.
  • Moritz RL; Department of Pharmaceutical Chemistry and Bioanalytics, Institute of Pharmacy, Martin-Luther University Halle-Wittenberg, Halle, Germany.
  • Sidhu SS; Department of Pediatrics, Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA, USA.
  • Huang L; Department of Pediatrics, Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA, USA.
  • Wiita AP; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.
Nat Cancer ; 4(11): 1592-1609, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37904046
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Receptores Quiméricos de Antígenos Límite: Humans Idioma: En Revista: Nat Cancer Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Receptores Quiméricos de Antígenos Límite: Humans Idioma: En Revista: Nat Cancer Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido